RANDI HUMMEL: Open Payments
NPI 1386005635 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,629 in 178 payments from 17 companies in 2025. Trend: 2023 $2,649 · 2024 $3,644 · 2025 $3,629
Food & beverage: $3,629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $1,069 |
| Janssen Biotech, Inc. | 20 | $428 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $316 |
| Lilly USA, LLC | 10 | $224 |
| Ardelyx, Inc. | 12 | $223 |
| GENZYME CORPORATION | 8 | $191 |
| Gilead Sciences, Inc. | 9 | $166 |
| PFIZER INC. | 15 | $166 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
Products named: RINVOQ, TREMFYA, DUPIXENT, XIFAXAN, SKYRIZI, ENTYVIO, OMVOH, IBSRELA.
Industry payments across IL — which companies pay providers there.
